Table 4. Multivariate analysis for factors associated with healthcare delay > 5 days.
| Variables | ≤ 5 days (n = 846) | > 5 days (n = 711) | P value | Multivariate analysis | |
|---|---|---|---|---|---|
| aOR (95% CI) | P value | ||||
| During COVID-19 pandemic | 428 (50.6) | 405 (57.0) | 0.012 | 1.267 (1.032–1.555) | 0.024 |
| Age ≥ 65 years | 412 (48.7) | 357 (50.2) | 0.552 | 1.154 (0.937–1.421) | 0.177 |
| Male | 529 (62.5) | 396 (55.7) | 0.006 | 0.795 (0.644–0.981) | 0.032 |
| Prior TB treatment | 136 (16.1) | 117 (16.5) | 0.840 | 1.117 (0.845–1.478) | 0.438 |
| Extrapulmonary involvement | 248 (29.3) | 293 (41.2) | < 0.001 | 1.588 (1.259–2.004) | < 0.001 |
| Cough ± sputum | 489 (57.8) | 340 (47.8) | < 0.001 | 0.766 (0.614–1.018) | 0.068 |
| Fever | 188 (22.2) | 139 (19.5) | 0.197 | 0.791 (0.614–1.018) | 0.068 |
| Alarming symptomsa | 364 (43.0) | 245 (34.5) | 0.001 | 0.644 (0.519–0.798) | < 0.001 |
| Diabetes | 183 (21.6) | 137 (19.3) | 0.250 | ||
| Solid malignancy | 52 (6.1) | 55 (7.7) | 0.217 | ||
Values are expressed as numbers and percentage.
aOR = adjusted odds ratio, CI = confidence interval, COVID-19 = coronavirus disease 2019, TB = tuberculosis.
aAlarming symptoms were defined as sum of chest discomfort, hemoptysis, or dyspnea.